ATRO Medical B.V.
ATRO Medical is an innovative medical device company founded in 2016, specializing in the development of artificial meniscus prostheses. Their mission is to improve the quality of life for knee patients suffering from chronic pain, through groundbreaking solutions like the Artimis® meniscus prosthesis. The company has received international recognition, including FDA breakthrough device designation, EU grants, and awards, and collaborates with research institutions and partners worldwide. They are actively involved in cutting-edge research projects, including AI-driven personalized meniscus solutions in collaboration with Radboudumc, and have been recognized as winners of the Johnson & Johnson Innovation Veterans Lead QuickFire Challenge.
Industries
Nr. of Employees
small (1-50)
ATRO Medical B.V.
Novio Tech Campus Transistorweg 5, 6534 AT Nijmegen (Headquarters)
Patents
Products
Anatomical meniscus prosthesis (PCU)
An anatomically shaped, non-biodegradable polymer meniscal implant intended to restore shock-absorbing function and redistribute load in the knee; designed for arthroscopic implantation with tibial fixation.
Anatomical meniscus prosthesis (PCU)
An anatomically shaped, non-biodegradable polymer meniscal implant intended to restore shock-absorbing function and redistribute load in the knee; designed for arthroscopic implantation with tibial fixation.
Services
Design and conduct of prospective clinical studies for implantable meniscal devices, including patient screening, on-site surgical coordination at participating hospitals, rehabilitation coordination and longitudinal outcome monitoring to generate clinical safety and performance data.
Collaborative development of MRI-to-implant workflows using artificial intelligence and additive manufacturing to produce patient-specific polymer meniscus prototypes and associated surgical tools; includes preclinical validation in academic research laboratories and development of surgical procedures.
Management of multi-party R&D consortia and administration of competitive public funding awards, including proposal preparation, coordination of multi-partner deliverables and liaison with funding agencies to execute co-funded SME projects.
Design and conduct of prospective clinical studies for implantable meniscal devices, including patient screening, on-site surgical coordination at participating hospitals, rehabilitation coordination and longitudinal outcome monitoring to generate clinical safety and performance data.
Collaborative development of MRI-to-implant workflows using artificial intelligence and additive manufacturing to produce patient-specific polymer meniscus prototypes and associated surgical tools; includes preclinical validation in academic research laboratories and development of surgical procedures.
Management of multi-party R&D consortia and administration of competitive public funding awards, including proposal preparation, coordination of multi-partner deliverables and liaison with funding agencies to execute co-funded SME projects.
Expertise Areas
- Clinical trial management for implantable orthopedic devices
- Arthroscopic surgical procedures for implant placement
- Biomaterials engineering for load-bearing implants (polycarbonate urethane)
- Patient-specific implant design using MRI and AI
Key Technologies
- Polycarbonate urethane (PCU) biomaterials
- Arthroscopic surgical techniques
- MRI-based anatomical modeling
- AI-driven anatomical/3D model generation
News & Updates
September 9th, 2025 - ATRO Medical presents at the US Plug&Play incubator.
October 11th, 2025 - Founder Tony van Tienen will present Artimis' clinical data.
ATRO Medical started a clinical trial on a lateral artificial meniscus, replacing an absent meniscus in the outer knee with the Artimis® Meniscus Prosthesis.
The Artimis® is the new name for the world's first artificial meniscus.
A clinical study initiated in October 2021 to evaluate the effectiveness of the Artimis® meniscus prosthesis, which is full and no longer accepting new participants.
A project combining sports medicine and AI to design a 3D-printed meniscus based on scans of healthy meniscus, for personalized treatment.
September 9th, 2025 - ATRO Medical presents at the US Plug&Play incubator.
October 11th, 2025 - Founder Tony van Tienen will present Artimis' clinical data.
ATRO Medical started a clinical trial on a lateral artificial meniscus, replacing an absent meniscus in the outer knee with the Artimis® Meniscus Prosthesis.
The Artimis® is the new name for the world's first artificial meniscus.
A clinical study initiated in October 2021 to evaluate the effectiveness of the Artimis® meniscus prosthesis, which is full and no longer accepting new participants.
A project combining sports medicine and AI to design a 3D-printed meniscus based on scans of healthy meniscus, for personalized treatment.